HomeNews

News

An Industry-First Solution to Tackle the Growing Hypertension Issue

The US Food and Drug Administration has formally approved Merck’s WINREVAIR therapeutic for the treatment of adults with pulmonary arterial hypertension (PAH). Understood to...

Hot Topics